Mesenchymal Stem Cell Culture within Perfusion Bioreactors Incorporating 3D‐Printed Scaffolds Enables Improved Extracellular Vesicle Yield with Preserved Bioactivity
Advanced Healthcare Materials · 2023-08 · 12 (20)
DOI: 10.1002/adhm.202300584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 02.04.2023. Verfasst von Stephanie M Kronstadt und 17 weiteren Autor:innen. Beteiligte Einrichtung: Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles, Mesenchymal Stem Cells. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are implicated as promising therapeutics and drug delivery vehicles in various diseases. However, successful clinical translation will depend on the development of scalable biomanufacturing approaches, especially due to the documented low levels of intrinsic EV‐associated cargo that may necessitate repeated doses to achieve clinical benefit in certain applications. Thus, here the effects of a 3D‐printed scaffold‐perfusion bioreactor system are assessed on the production and bioactivity of EVs secreted from bone marrow‐derived mesenchymal stem cells (MSCs), a cell type widely implicated in generating EVs with therapeutic potential. The results indicate that perfusion bioreactor culture induces an ≈40‐80‐fold increase (depending on measurement method) in MSC EV production compared to conventional cell culture. Additionally, MSC EVs generated using the perfusion bioreactor system significantly improve wound healing in a diabetic mouse model, with increased CD31 + staining in wound bed tissue compared to animals treated with flask cell culture‐generated MSC EVs. Overall, this study establishes a promising solution to a major EV translational bottleneck, with the capacity for tunability for specific applications and general improvement alongside advancements in 3D‐printing technologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA.
- Hendrix Burn and Wound Healing Laboratory, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, 21224, USA.
- Program in Molecular and Cell Biology, University of Maryland, College Park, MD, 20742, USA.
ORCID-Profile: Steven M Jay
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
- NINDS NIH HHS
- NIBIB NIH HHS
- National Institutes of Health
- National Science Foundation
- American Heart Association
Zitieren
APA
Kronstadt, S. M., Patel, D. B., Born, L. J., Levy, D., Lerman, M. J., Mahadik, B., McLoughlin, S. T., Fasuyi, A., Fowlkes, L., Van Heyningen, L. H., Aranda, A., Abadchi, S. N., Chang, K. H., Hsu, A. T. W., Bengali, S., Harmon, J. W., Fisher, J. P., & Jay, S. M. (2023). Mesenchymal Stem Cell Culture within Perfusion Bioreactors Incorporating 3D‐Printed Scaffolds Enables Improved Extracellular Vesicle Yield with Preserved Bioactivity. Advanced Healthcare Materials, 12(20). https://doi.org/10.1002/adhm.202300584
Vancouver
Kronstadt SM, Patel DB, Born LJ, Levy D, Lerman MJ, Mahadik B, et al. Mesenchymal Stem Cell Culture within Perfusion Bioreactors Incorporating 3D‐Printed Scaffolds Enables Improved Extracellular Vesicle Yield with Preserved Bioactivity. Advanced Healthcare Materials. 2023;12(20). doi:10.1002/adhm.202300584
BibTeX
@article{Kronstadt2023,
author = {Kronstadt, Stephanie M and Patel, Divya B and Born, Louis J and Levy, Daniel and Lerman, Max J and Mahadik, Bhushan and McLoughlin, Shannon T and Fasuyi, Arafat and Fowlkes, Lauren and Van Heyningen, Lauren Hoorens and Aranda, Amaya and Abadchi, Sanaz Nourmohammadi and Chang, Kai-Hua and Hsu, Angela Ting Wei and Bengali, Sameer and Harmon, John W and Fisher, John P and Jay, Steven M},
title = {Mesenchymal Stem Cell Culture within Perfusion Bioreactors Incorporating 3D‐Printed Scaffolds Enables Improved Extracellular Vesicle Yield with Preserved Bioactivity},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {20},
doi = {10.1002/adhm.202300584}
}
EUVIMED